Form 4: Outset Medical CFO Executes Sell-to-Cover Transaction

CFO Renee Gaeta sold 17,672 shares of Outset Medical common stock to satisfy tax withholding obligations related to RSU vesting.

Summary

• Renee Gaeta, Chief Financial Officer of Outset Medical, Inc., sold 17,672 shares of common stock.
• The transaction occurred on June 3, 2026, at a price of $4.94 per share.
• The sale was a mandatory 'sell to cover' transaction to satisfy tax withholding obligations.
• The transaction was triggered by the vesting of 32,856 restricted stock units (RSUs) granted on June 10, 2025.
• Following this transaction, the reporting person retains 113,753 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a routine administrative transaction required for tax compliance rather than a market-driven divestment.

Positives

• The transaction was non-discretionary and strictly for tax compliance purposes, indicating no change in management's long-term outlook on the company.

Negatives

• The sale reduces the direct equity stake held by the CFO, though the reduction is purely administrative.

Risks

• None identified; this is a routine regulatory filing regarding tax obligations.

Future Outlook

Not applicable; this is a retrospective disclosure of a past transaction.

Management Comments

• The sale was made to satisfy tax withholding obligations through a 'sell to cover' transaction and does not represent a discretionary trade by the reporting person.

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are standard corporate governance practices for executives receiving equity-based compensation and do not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction follows standard SEC reporting requirements for executive equity compensation.
• The use of 'sell to cover' is a common industry practice for managing tax liabilities associated with RSU vesting.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was non-discretionary.

Next Steps

• No further actions required by the reporting person regarding this specific transaction.

Key Dates

Keywords

Outset Medical, OM, Insider Trading, Form 4, CFO, Tax Withholding, Equity Compensation